University Hospital Coventry research team shortlisted for NHS Clinical Research Site of the Year

University Hospitals Coventry and Warwickshire NHS Trust have been shortlisted for a top national award. The team are finalists for the fifth year running for the NHS Clinical Research Site of the Year 2017 in the PharmaTimes International Clinical Researcher of the Year Awards 2017.

This is a national award by the PharmaTimes in collaboration with the National Institute for Health Research (NIHR). Reaching the final indicates to the NIHR and the wider industry that the Trust is a place where high quality research happens.

This will be the fifth year in a row that UHCW has been in the final. The award is a team competition, open to NHS organisations in the UK. The competition is judged by the NIHR and the Association of the British Pharmaceutical Industry (ABPI). The judges are looking for outstanding communication skills as a team, and excellence in a real understanding of the NHS clinical research environment, working with external stakeholders and the life-sciences industry.

The team from Research and Development at University Hospital passed two rounds of challenges to reach the finals. The final will be held on March 23, 2017. The winners will be announced at an awards ceremony on Thursday, May 18, 2017.

Clinical trials are an important step in discovering new treatments to improve patient benefit, and through high-quality clinical research we can learn how to improve NHS healthcare for the future. The award gives high-profile recognition of the role the NHS plays in initiating and delivering clinical research with the life sciences industry, and its contribution to the international competitiveness of the UK.

Professor Chris Imray, Director of Research and Development, said:
“This award is important as it recognises the key role that NHS Research and Development teams provide to the pharmaceutical industry. Our local knowledge and relationships speed up the set up and delivery of clinical trials for our partners. Research helps us deliver better outcomes for our patients who have the opportunity to take part in trials of new treatments. Although the work we do is challenging and we are always busy, we are delighted that this award recognises the great job we do.”